WP 1097
Alternative Names: WP-1097Latest Information Update: 28 Nov 2024
Price :
$50 *
At a glance
- Originator Moleculin Biotech
- Class Antivirals; Small molecules
- Mechanism of Action Coronavirus spike glycoprotein modulators; Glycolysis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Viral haemorrhagic fevers
- No development reported COVID 2019 infections; Dengue; HIV infections; Zika virus infection
Most Recent Events
- 28 Nov 2024 No recent reports of development identified for preclinical development in COVID-2019-infections in USA
- 28 Nov 2024 No recent reports of development identified for preclinical development in Dengue in USA
- 28 Nov 2024 No recent reports of development identified for preclinical development in HIV-infections in USA